Q32 Bio, Inc. (QTTB)
8.74
+0.40
(+4.80%)
USD |
NASDAQ |
Oct 12, 16:00
8.74
0.00 (0.00%)
After-Hours: 20:00
Q32 Bio Cash from Investing (Quarterly) : 0.00 for June 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.00 |
| March 31, 2026 | 0.00 |
| December 31, 2025 | 7.00M |
| September 30, 2025 | 0.00 |
| June 30, 2025 | 0.00 |
| March 31, 2025 | 0.00 |
| December 31, 2024 | -0.002M |
| September 30, 2024 | 9.942M |
| June 30, 2024 | 9.888M |
| March 31, 2024 | 0.097M |
| December 31, 2023 | 0.00 |
| September 30, 2023 | -0.001M |
| June 30, 2023 | 0.001M |
| March 31, 2023 | -0.005M |
| December 31, 2022 | 17.99M |
| September 30, 2022 | -108.22M |
| June 30, 2022 | -41.37M |
| March 31, 2022 | 168.31M |
| Date | Value |
|---|---|
| December 31, 2021 | 43.66M |
| September 30, 2021 | 4.524M |
| June 30, 2021 | -13.74M |
| March 31, 2021 | -85.24M |
| December 31, 2020 | -0.955M |
| September 30, 2020 | 38.84M |
| June 30, 2020 | 52.01M |
| March 31, 2020 | 115.00M |
| December 31, 2019 | -20.03M |
| September 30, 2019 | -13.14M |
| June 30, 2019 | -38.30M |
| March 31, 2019 | 19.67M |
| December 31, 2018 | 10.20M |
| September 30, 2018 | -45.26M |
| June 30, 2018 | -93.37M |
| March 31, 2018 | 6.64M |
| December 31, 2017 | -79.90M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Intellia Therapeutics, Inc. | -141.57M |
| Beam Therapeutics, Inc. | -9.875M |
| Prime Medicine, Inc. | 24.03M |
| Prelude Therapeutics, Inc. | -65.50M |
| Twist Bioscience Corp. | -10.20M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -3.075M |
| Cash from Financing (Quarterly) | 58.59M |
| Free Cash Flow | -19.83M |
| Free Cash Flow Per Share (Quarterly) | -0.1512 |
| Free Cash Flow to Equity (Quarterly) | 5.275M |
| Free Cash Flow to Firm (Quarterly) | -2.275M |
| Free Cash Flow Yield | -15.31% |